期刊文献+

质子泵抑制剂的合理应用及其影响因素 被引量:25

Application and influencing factors of proton pump inhibitor
下载PDF
导出
摘要 目的探讨质子泵抑制剂(PPI)作用的影响因素,促进临床合理用药。方法综述PPI的作用原理及临床应用研究,探讨质子泵抑制剂的药效影响因素。结果 PPI的药效与用药时间、患者的情绪及基因多态性等多种因素有关。结论临床合理用药方案的制定应综合考虑多方面因素。 Objective To discuss the appropriate use and influencing factors of proton pump inhibitor(PPI). Methods The mechanism of action and the studies of clinical application of PPI were reviewed. Results The actions of PPI are affected by many influencing factors,such as dose time,patients' mood,gene polymorphisms of patients,and so on. Conclusion A reasonable dosage schedule should be based on an overall consideration of various factors.
作者 谭爱萍
出处 《实用药物与临床》 CAS 2011年第2期159-160,共2页 Practical Pharmacy and Clinical Remedies
关键词 质子泵抑制剂(PPI) 合理用药 影响因素 Proton pump inhibitor(PPI) Rational drug use Influencing factor
  • 相关文献

参考文献10

二级参考文献141

  • 1凌明德 杜美娟.奥美拉唑在生殖系统的不良反应3例[J].新消化病学杂志,1996,4(3):161-161.
  • 2钱玉明.奥美拉唑引起严重脱发1例[J].新药与临床,1994,13(5):312-312.
  • 3SavarinoV.抑酸治疗的新纪元[N].中国医学论坛报,2001.09—06(4).
  • 4Andersson T, Rohss K, Kassan-Alin M, et al. Pharmacokinetics(PK) and dose-response relationship of esomeprazole [ J ]. Gastroenterology,2000,118(4 Suppl 2) :A 5550.
  • 5[1]Huber R, Kohl B, Sachs G, et al. The continuing development of proton pump inhibitors with particular reference to pantorazole [J]. Aliment Pharmacol Ther , 1995,9:363.
  • 6[2]Blum RA.Lansoprazol and omeprazol in the treatment of acid peptic disorders[J]. Am J Health-Syst Pharm , 1996,53:1401.
  • 7[3]Chiverton SG, Howden CW, Burget DW, et al. Omeprazole (20 mg)daily given in the morning or evening: a comparison of effects on gastric acidity,and plasma gastrin and omeprazole concentration[J] .Aliment Pharmacol Ther,1992,6:103.
  • 8[4]Savarino V, Mela GS, Zentilin P, et al. Variability in individual response to various doses of omeprazole: implication for anti-unlcertherapy[J]. Dig Dis Sci, 1994,39(1):161.
  • 9[5]Bergatrand R.Decreased oral bioavialability of lansoprazole in healthy clunteeres when given with a standardized breakfast[J]. Clin Drug Invest, 1995,9:67.
  • 10[6]Katz PO, Anderson C, Khoury R, et al, Gastro-esophageal reflux associated with nocturnal gastric acid breakthrough on proton pump inhibitors[J]. Aliment Pharmacol Ther , 1998,12:1231.

共引文献245

同被引文献147

引证文献25

二级引证文献78

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部